Application of AI on Cholangiocarcinoma

Overview

Journal Front Oncol

Specialty Oncology

Date 2024 Feb 13

PMID 38347839

Authors

Jianhao Huang

Xuesong Bai

Yanyu Qiu

Xiaodong He

Affiliations

Soon will be listed here.

Abstract

Cholangiocarcinoma, classified as intrahepatic, perihilar, and extrahepatic, is considered a deadly malignancy of the hepatobiliary system. Most cases of cholangiocarcinoma are asymptomatic. Therefore, early detection of cholangiocarcinoma is significant but still challenging. The routine screening of a tumor lacks specificity and accuracy. With the application of AI, high-risk patients can be easily found by analyzing their clinical characteristics, serum biomarkers, and medical images. Moreover, AI can be used to predict the prognosis including recurrence risk and metastasis. Although they have some limitations, AI algorithms will still significantly improve many aspects of cholangiocarcinoma in the medical field with the development of computing power and technology.

Citing Articles

Introducing and Validating the Multiphasic Evidential Decision-Making Matrix (MedMax) for Clinical Management in Patients with Intrahepatic Cholangiocarcinoma.

Ramouz A, Adeliansedehi A, Khajeh E, Marz K, Michael D, Wagner M Cancers (Basel). 2025; 17(1.

PMID: 39796681 PMC: 11718823. DOI: 10.3390/cancers17010052.

Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature.

Mattiolo P, De Bellis M, Mafficini A, Fassan M, Bevere M, Ciulla C J Gastrointest Cancer. 2024; 55(4):1634-1646.

PMID: 39283582 PMC: 11464565. DOI: 10.1007/s12029-024-01113-8.

References

Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B . Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019; 39 Suppl 1:7-18. DOI: 10.1111/liv.14093. View

Peng Y, Lin P, Wu L, Wan D, Zhao Y, Liang L . Ultrasound-Based Radiomics Analysis for Preoperatively Predicting Different Histopathological Subtypes of Primary Liver Cancer. Front Oncol. 2020; 10:1646. PMC: 7543652. DOI: 10.3389/fonc.2020.01646. View

Obermeyer Z, Emanuel E . Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016; 375(13):1216-9. PMC: 5070532. DOI: 10.1056/NEJMp1606181. View

Bollwein C, Gonalves J, Utpatel K, Weichert W, Schwamborn K . MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree. Molecules. 2022; 27(11). PMC: 9182561. DOI: 10.3390/molecules27113464. View

Shao F, Huang Q, Wang C, Qiu L, Hu Y, Zha S . Artificial Neural Networking Model for the Prediction of Early Occlusion of Bilateral Plastic Stent Placement for Inoperable Hilar Cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech. 2017; 28(2):e54-e58. DOI: 10.1097/SLE.0000000000000502. View

Watcharatanyatip K, Chutipongtanate S, Chokchaichamnankit D, Weeraphan C, Mingkwan K, Luevisadpibul V . Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study. Molecules. 2022; 27(18). PMC: 9501115. DOI: 10.3390/molecules27185904. View

Swanson K, Wu E, Zhang A, Alizadeh A, Zou J . From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell. 2023; 186(8):1772-1791. DOI: 10.1016/j.cell.2023.01.035. View

Groot Koerkamp B, Wiggers J, Allen P, Busch O, DAngelica M, DeMatteo R . American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB (Oxford). 2014; 16(12):1074-82. PMC: 4253330. DOI: 10.1111/hpb.12320. View

Midya A, Chakraborty J, Srouji R, Narayan R, Boerner T, Zheng J . Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach. IEEE J Biomed Health Inform. 2023; 27(5):2456-2464. PMC: 10245221. DOI: 10.1109/JBHI.2023.3248489. View

10.

Razumilava N, Gores G . Cholangiocarcinoma. Lancet. 2014; 383(9935):2168-79. PMC: 4069226. DOI: 10.1016/S0140-6736(13)61903-0. View

11.

Wang D, Pan B, Huang J, Chen Q, Cui S, Lang R . Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma. Front Oncol. 2023; 13:1106029. PMC: 10050553. DOI: 10.3389/fonc.2023.1106029. View

12.

Guo L, Li X, Zhang C, Xu Y, Han L, Zhang L . Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study. J Hepatocell Carcinoma. 2023; 10:795-806. PMC: 10243611. DOI: 10.2147/JHC.S406648. View

13.

Venkatesh P, Navaneethan U, Shen B, McCullough A . Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma. Dig Dis Sci. 2012; 58(3):850-7. DOI: 10.1007/s10620-012-2401-3. View

14.

Tang Y, Yang C, Su S, Wang W, Fan L, Shu J . Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma. BMC Cancer. 2021; 21(1):1268. PMC: 8611922. DOI: 10.1186/s12885-021-08947-6. View

15.

Raoof M, Dumitra S, Ituarte P, Melstrom L, Warner S, Fong Y . Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma. JAMA Surg. 2017; 152(5):e170117. PMC: 5624806. DOI: 10.1001/jamasurg.2017.0117. View

16.

Gao L, Lin Y, Yue P, Li S, Zhang Y, Mi N . Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma. BMC Med. 2023; 21(1):294. PMC: 10408060. DOI: 10.1186/s12916-023-02990-9. View

17.

Bai Y, Liu Z, Xiong J, Xu W, Lin J, Long J . Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol. 2018; 24(45):5167-5178. PMC: 6288645. DOI: 10.3748/wjg.v24.i45.5167. View

18.

Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques H . Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection. Surgery. 2019; 166(6):983-990. DOI: 10.1016/j.surg.2019.06.005. View

19.

Giordano S, Takeda S, Donadon M, Saiki H, Brunelli L, Pastorelli R . Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligence. Liver Int. 2020; 40(12):3117-3124. PMC: 7754124. DOI: 10.1111/liv.14604. View

20.

Wu J, Guo Y, Zuo Z, Zhu Z, Han L . is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. World J Gastroenterol. 2023; 29(19):2961-2978. PMC: 10237093. DOI: 10.3748/wjg.v29.i19.2961. View